0001371796-21-000001.txt : 20210209 0001371796-21-000001.hdr.sgml : 20210209 20210209130710 ACCESSION NUMBER: 0001371796-21-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210209 DATE AS OF CHANGE: 20210209 EFFECTIVENESS DATE: 20210209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solace Therapeutics Inc CENTRAL INDEX KEY: 0001371796 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-360376 FILM NUMBER: 21605165 BUSINESS ADDRESS: STREET 1: 135 NEWBURY STREET CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 508-283-1200 MAIL ADDRESS: STREET 1: 135 NEWBURY STREET CITY: FRAMINGHAM STATE: MA ZIP: 01701 D/A 1 primary_doc.xml X0708 D/A LIVE 0001371796 Solace Therapeutics Inc 135 NEWBURY STREET FRAMINGHAM MA MASSACHUSETTS 01701 508-283-1200 DELAWARE None None Corporation true William H. Gruber 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Executive Officer Director Kevin G. Connors 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Director Brian R. Smith 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Director John McDonough 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Director David Neustaedter 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Director Other Health Care Decline to Disclose 06b true 0001371796-20-000002 2020-01-30 true true false 0 17602367 6527367 11075000 false 8 0 0 0 false Solace Therapeutics Inc William H. Gruber William H. Gruber Chief Executive Officer 2021-02-09